BioSpace News Archive

Press Releases

Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors

April 30, 2026
·
5 min read
Press Releases

Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)

April 30, 2026
·
5 min read
Press Releases

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

April 30, 2026
·
7 min read
Press Releases

Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer

April 30, 2026
·
6 min read
Press Releases

Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio

April 30, 2026
·
6 min read
Press Releases

Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

April 30, 2026
·
4 min read
Press Releases

AVITA Medical Names Cary Vance as Chief Executive Officer

April 30, 2026
·
6 min read
Press Releases

Vicarious Surgical Reports First Quarter 2026 Financial Results

April 30, 2026
·
7 min read
Press Releases

NAMSA and Lexitas Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development

April 30, 2026
·
4 min read
Press Releases

Kriya Announces Presentations at ASGCT 2026 Highlighting Advances Across Gene Therapy Platform

April 30, 2026
·
3 min read